SIRT1 and coronary artery disorder: More recently, the protective role of SIRT1 was confirmed in a study aiming at assessing the mechanisms sustaining the beneficial effects of ticagrelor compared to clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease undergoing percutaneous coronary intervention.